Catalyst Wire Dossier Catalyst Wire Dossier

V181 Dengue Vaccine

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for V181 Dengue Vaccine, covering 2025-05-09 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1) [Phase 3]

See pricing